Key result
Framingham and reduced DAD scores show 49% agreement in high-risk HIV patients.
Why the study?
HIV-positive patients have increased and earlier cardiovascular risk, and the comparative utility of Framingham and reduced DAD scores for risk assessment is unclear.
How do Framingham 2008 and reduced DAD scores compare in assessing cardiovascular risk and correlating with subclinical carotid atherosclerosis in HIV-positive patients?
Cross-Sectional (n=71)
How do Framingham 2008 and reduced DAD scores compare in assessing cardiovascular risk and correlating with subclinical carotid atherosclerosis in HIV-positive patients?
Effect estimate: Kappa 0.735
A high prevalence of subclinical carotid atherosclerosis in HIV-positive patients classified as intermediate risk by Framingham or reduced DAD scores suggests these patients may need reclassification to high risk.
Intermediate-risk HIV patients often show carotid atherosclerosis by either score; hypothesis-generating for reclassification pending prospective validation.
BACKGROUND: HIV-positive patients are twice as likely than the general population to have a heart attack and are four times at greater risk of sudden death. In addition to the increased risk, these individuals present with cardiovascular events on average approximately 10 years earlier than the general population. OBJECTIVE: To compare Framingham and reduced DAD (Data Collection on Adverse Effects of Anti-HIV Drugs Cohort) scores for cardiovascular risk assessment in HIV-positive patients and potential impact on clinical decision after evaluation of subclinical carotid atherosclerosis. METHODS: Seventy-one HIV-positive patients with no history of cardiovascular disease were clinically evaluated, stratified by the Framingham 2008 and reduced DAD scores and submitted to subclinical carotid atherosclerosis evaluation. Agreement between scores was assessed by Kappa index and p < 0.05 was considered statistically significant. RESULTS: mean age was 47.2 and 53.5% among males. The rate of subclinical atherosclerosis was 39.4%. Agreement between scores was 49% with Kappa of 0.735 in high-risk patients. There was no significant difference between scores by ROC curve discrimination analysis. Among patients with intermediate risk and Framingham and reduced DAD scores, 62.5% and 30.8% had carotid atherosclerosis, respectively. CONCLUSION: The present study showed a correlation between the scores and medium-intimal thickening, besides a high correlation between patients classified as high risk by the Framingham 2008 and reduced DAD scores. The high prevalence of carotid atherosclerosis in intermediate risk patients suggests that most of them could be reclassified as high risk.
No takes yet. Share an insight, caveat, or question.
Silva et al. (2020) conducted a cross-sectional in HIV-positive with no history of cardiovascular disease (n=71). Framingham 2008 score vs. reduced DAD score was evaluated on Agreement between scores in high-risk patients (Kappa 0.735). Framingham 2008 and reduced DAD scores demonstrated 49% agreement (Kappa 0.735) in high-risk HIV-positive patients, with 62.5% and 30.8% of intermediate-risk patients having carotid atherosclerosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: